RxDoctor Payments Data

Sarah Bell, PA

Physician Assistant · Knoxville, TNNPI 1982352944

Payments from drug & device makers

$1,726in general payments, 2019–2025

Across 97 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$391
  • Otsuka America Pharmaceutical, Inc.$302
  • AbbVie$276
  • Novo Nordisk$221
  • Lilly USA, LLC$60
  • Takeda Pharmaceuticals U.S.A., Inc.$58
  • plus $420 from 14 others

What the payments were for

  • Food & beverage$1,70899%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,726 in reported general payments places this provider in the 75th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$21,119
Medicare patients
67
Services billed
357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide78$92,602
OzempicSemaglutide51$59,218
FarxigaDapagliflozin Propanediol22$28,734
Nurtec OdtRimegepant Sulfate14$23,305
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$16,229
XareltoRivaroxaban27$13,958
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$12,973
JardianceEmpagliflozin13$10,418
EntrestoSacubitril/Valsartan17$10,017
RybelsusSemaglutide11$9,796
JentaduetoLinagliptin/Metformin Hcl13$6,267
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$6,221
SymbicortBudesonide/Formoterol Fumarate13$3,304
Gabapentin161$1,929
Atorvastatin Calcium165$1,915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$60$92,60278 claims
Novo NordiskOzempic, Rybelsus$221$69,01462 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$391$45,01153 claims
PfizerNurtec Odt$53$23,30514 claims
Boehringer IngelheimJardiance, Jentadueto$36$16,68526 claims
GSKTrelegy Ellipta$14$16,22911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →